Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2007 Oct 19.
Published in final edited form as: Spinal Cord. 2006 Dec 19;45(9):616–620. doi: 10.1038/sj.sc.3102004

Proteus bacteriuria is associated with significant morbidity in spinal cord injury

EW Hung 1, RO Darouiche 2,3, BW Trautner 2,3,*
PMCID: PMC2038981  NIHMSID: NIHMS31976  PMID: 17179975

Abstract

Study Design

Retrospective chart review.

Objectives

We investigated the morbidity associated with Proteus bacteriuria in a spinal cord injured (SCI) population.

Setting

Michael E DeBakey Veterans Affairs Medical Center in Houston, Texas, USA.

Methods

We reviewed the medical records of all veterans with SCI who received care in our medical center during the past 3 years. Proteus bacteriuria was defined as the growth of Proteus species in any urine culture during the study period. Urinary stones were defined as either renal or bladder calculi.

Results

During the study period, 71 of the 501 subjects (14%) had Proteus and 90 (18%) had urinary stones. Twenty-seven percent of the subjects with Proteus had stones, and the association of Proteus with stones was significant (P<0.05). Proteus bacteriuria was likewise associated with complete injury, hospitalization, decubitus ulcers, and history of stones (P<0.001). Subjects using indwelling catheters, either transurethral or suprapubic, were significantly more likely to have Proteus, whereas subjects practising spontaneous voiding and clean intermittent catheterization were significantly less likely to have Proteus. In the 90 patients with stones, Proteus was associated with requiring treatment for stones and having multiple stones (P<0.01). Twenty-five of the 90 patients with stones (28%) required treatment, most often with lithotripsy, and 6 (7%) developed urosepsis.

Conclusions

In persons with SCI, Proteus was found in subjects with a greater degree of impairment who were more likely to be hospitalized, to have decubiti, and to use indwelling catheters. Bacteriuria with Proteus predicted urologic complications in persons with SCI.

Statement of Ethics

All applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during the course of this research.

Sponsorship

This work was supported by USPHS grant HD42014.

Keywords: spinal cord injury, bacteriuria, Proteus, urinary stones

Introduction

Patients with spinal cord injury (SCI) and neurogenic bladders are at high risk for recurrent urinary tract infections. Predisposing factors include impaired bladder emptying, repeated instrumentation, vesiculoureteral reflux, and indwelling urinary catheters.1 Patients with SCI are also prone to the development of bladder and renal stones.2,3 One link between chronic bacteriuria and the formation of stones is infection of the urinary tract with urease-producing organisms.4 Urease splits the urea present in urine to form ammonia and carbon dioxide, thus raising urinary pH and causing normally soluble ions to precipitate and form stones.5 Several bacterial species that commonly infect neurogenic bladders can split urease, including Klebsiella, Providencia, Morganella, Pseudomonas, and Proteus. As the Proteus urease has the fastest rate of urea hydrolysis,4,6 Proteus is the organism most commonly implicated in catheter encrustation, catheter blockage, and stone formation in the urinary tracts of individuals with indwelling catheters. Antimicrobial therapy often fails to eradicate Proteus and other organisms embedded in the crevices of stones.7

Infectious complications of Proteus bacteriuria have been well documented in the general population of persons with indwelling catheters or abnormal urinary tracts.7 However, the outcomes of Proteus bacteriuria specifically in persons with SCI have not been described. Accordingly, we sought to define the relationship in the SCI population between Proteus bacteriuria and the presence of urinary complications, including stones.

Methods

Study design

A retrospective chart review of the electronic medical record was performed on all veterans with SCI who had received care at the Michael E DeBakey Veterans Affairs Medical Center over the 3 previous years, from 1 January 2003 to 2 January 2006. Patients who had undergone urinary diversion/ileostomy were excluded. Demographic information collected included age, time since injury, ethnicity, level of SCI, complete versus incomplete injury, substance abuse (alcohol, illicit drugs, and tobacco), and type of bladder management. In subjects who had more than one type of bladder management during the study period, all methods used were recorded. Thus, each subject could have several types of bladder management. Medical information collected included whether the subject was hospitalized, treated for a decubitus ulcer, treated for diabetes, developed urosepsis, had a prior history of stones, or required treatment for stones during the study period.

Microbiology

All urine cultures collected from subjects during the study period were reviewed. Any organism identified to the genus level was recorded. Proteus bacteriuria was defined as the growth of Proteus species in any urine culture during the study period. Urinalysis data were collected from all urine specimens corresponding to a documented episode of Proteus bacteriuria.

Definitions of stones

Stones were defined as either renal or bladder calculi during the 3-year time frame of the study. Multiple stones was defined as the presence of >1 stone during the time period, regardless of whether the multiple stones were present at the same time or separated in time. Treatments for stones included nephrostomy tube placement, lithotripsy, and surgical removal.

Statistical analysis

Data were compared using SAS (Release 8.2). The Fisher exact test was used for all pairwise comparisons, and logistic regression was used for multivariate analysis.

Results

Demographics

Our medical center currently serves 596 veterans with SCI. We excluded a total of 95 patients for not being seen at our medical center during the study period (71 patients) or for having had urinary diversion (24 patients). Demographic information on the remaining 501 subjects is shown in Table 1. The median age was 57.5 years (interquartile range 50–63 years) and the median time since injury was 15 years (interquartile range 5–26 years). Only 4 subjects had bladder stones, and 1 of these 4 had both bladder and renal stones. The type of bladder management from the most common to the least common was clean intermittent catheterization (N = 230), spontaneous voiding (N = 136), indwelling Foley catheter (N = 99), external condom catheter (N = 98), and suprapubic tube (N = 56).

Table 1.

Demographic information

Frequency (N = 501) %
Gender
 Male 491 98
 Female 10 2
Ethnicitya
 African-American 172 35
 Latino 22 4.5
 Caucasian 297 60
 Other 3 0.6
Hospitalized 279 56
Diabetes mellitus 109 22
Decubitus ulcer 209 42
Drug abuse 61 12
Alcohol abuse 85 17
Tobacco abuse 184 37
History of stones 91 18
Stones during study 90 18
Proteus bacteriuria 71 14
a

N = 494 as no racial information was noted in 7 patients

Medical conditions

The following conditions were associated with having Proteus bacteriuria: complete injury, hospitalization, decubitus ulcer, and a history of stones (Table 2). Veterans with tobacco abuse were less likely to have Proteus in the urine. Complete injury, hospitalization, decubitus ulcer, and tobacco abuse remained significant predictors in multivariate analysis (P<0.02). Only hospitalization, decubitus ulcer, and a history of stones were associated with having stones (Table 2), and in the multivariate analysis only decubitus ulcer and a history of stones remained significant predictors of stones (P<0.03). Not surprisingly, hospitalization was significantly associated with decubitus ulcer (P<0.0001). Time since SCI did not prove to be significantly related to Proteus bacteriuria, decubitus ulcer, stones, or type of bladder management.

Table 2.

Association of medical conditions with Proteus bacteriuria or stones

Condition N Proteus N (%) P for Proteus comparisona Stones N (%) P for stone comparisona
Completeness of injury
 Complete 181 41 (22.7) 38 (21)
 Incomplete 320 30 (9.4) <0.0001 52 (16.3) 0.19
Level of injury
 Paraplegia 256 32 (12.5) 46 (18)
 Quadriplegia 244 38 (15.6) 0.37 43 (17.6) 1.0
Hospitalization
 Yes 279 58 (21) 59 (21.2)
 No 222 13 (5.9) <0.0001 31 (14) 0.046
Diabetes mellitus
 Yes 109 21 (19.2) 24 (22)
 No 392 50 (12.8) 0.09 66 (16.8) 0.21
Decubitus ulcer
 Yes 209 54 (25.8) 47 (22.5)
 No 292 17 (5.8) <0.0001 43 (14.7) 0.03
History of stones
 Yes 91 19 (20.9) 39 (42.9)
 No 410 52 (12.7) 0.047 51 (12.4) <0.0001
Drug abuse
 Yes 61 12 (19.7) 6 (9.8)
 No 440 59 (13.4) 0.24 84 (19.1) 0.11
Alcohol abuse
 Yes 85 12 (14.1) 16 (18.8)
 No 416 59 (14.2) 1.00 74 (17.8) 0.88
Tobacco abuse
 Yes 184 16 (8.7) 35 (19)
 No 317 55 (17.4) 0.008 55 (17.4) 0.63
a

All comparisons were carried out using the Fisher exact test

Microbiology

Many of the bacterial species cultured from subjects’ urine were strongly associated with having Proteus bacteriuria during the study period. These organisms included Staphylococcus aureus, Enterococcus, Escherichia coli, Pseudomonas, Morganella, group B Streptococcus, Providencia, and Candida (P<0.001). Serratia was also significantly associated with Proteus bacteriuria (P<0.04). A statistically insignificant trend was noted between Acinetobacter and Proteus bacteriuria (P = 0.06). Organisms not significantly associated with Proteus bacteriuria included Enterobacter, Klebsiella, Citrobacter, and Alcaligenes. Of the 71 subjects diagnosed with Proteus in their urine at some point during the study period, 19 (27%) were also diagnosed with stones (P = 0.045). Other organisms associated with the presence of stones included Enterococcus, Klebsiella, Pseudomonas, Morganella, and Providencia (P<0.05).

Bladder management

Subjects using indwelling catheters, either transurethral or suprapubic, were significantly more likely to have Proteus bacteriuria (P<0.001), whereas subjects practising spontaneous voiding and clean intermittent catheterization were significantly less likely to have Proteus bacteriuria (P<0.01) (Table 3). The association between external catheter use and Proteus was not significant in either direction. Of these types of bladder management, only suprapubic catheters were significantly associated with stones (P = 0.04). The association of indwelling catheters with stones nearly reached significance (P = 0.08), and spontaneous voiding was nearly significantly protective against having stones (P = 0.07). Indwelling Foley catheters, external catheters, and suprapubic catheters were also significantly associated with having decubitus ulcer (P<0.02).

Table 3.

Association of bladder management strategy with Proteus or stones

Bladder management N Proteus N (%) P for Proteus comparisona Stones N (%) P for stone comparisona
Spontaneous voiding
 Yes 136 5 (3.7) 17 (12.5)
 No 365 66 (18.1) <0.0001 73 (20) 0.07
Suprapubic catheter
 Yes 56 18 (32.1) 16 (28.6)
 No 445 53 (11.9) 0.0003 74 (16.6) 0.04
Indwelling foley
 Yes 99 26 (26.3) 24 (24.2)
 No 402 45 (11.2) 0.0003 66 (16.4) 0.08
External catheter
 Yes 98 17 (17.4) 15 (15.3)
 No 403 54 (13.4) 0.33 75 (18.6) 0.56
Clean intermittent catheterization
 Yes 230 22 (9.6) 43 (18.7)
 No 271 49 (18.1) 0.007 47 (17.3) 0.73
a

All comparisons were carried out using the Fisher exact test

Analysis of subjects with stones

During the study period, 90 SCI patients were diagnosed with either bladder or renal stones. In these subjects, having Proteus bacteriuria was associated with requiring treatment for stones and having multiple stones (P<0.01). Of the 90 patients with stones, 25 (28%) required treatment, most often with lithotripsy (22/25, 88%). Six of the 90 (7%) patients with stones developed urosepsis.

Urinalysis data

When available, urinalysis data were recorded during each episode of Proteus bacteriuria. These results appear in Table 4. Means differ considerably from medians owing to the presence of outliers in each category. For example, one urine sample had 15 429 wbc/hpf, whereas another urine sample had 5100 rbc/hpf. Of note, the urinary pH was slightly basic, as expected. Also, 66% of such urines had large leukocyte esterase and 43% had a positive nitrite test.

Table 4.

Urinalysis data during episodes of Proteus bacteriuria

Urinary findings Median IQRa Mean
White blood cells/hpf 34 11–112 351
Red blood cells/hpf 6 1–35 102
pH 7.5 6.5–8.0 7.35
a

Interquartile range

Conclusions

Our study confirms that bacteriuria with Proteus predicts urologic complications in persons with SCI. Proteus bacteriuria was more common in persons who had a greater degree of spinal cord impairment, were hospitalized, had decubitus ulcers, and used indwelling catheters. Proteus bacteriuria was associated with having stones, and subjects with both Proteus and stones were more likely to require treatment for stones or have multiple stones. Thus, the presence of Proteus in the bladder is not a benign condition and may be a marker for poor urinary tract health overall.

The association between Proteus bacteriuria and other nosocomial urinary pathogens was not surprising. Several of the less common nosocomial pathogens were not significantly associated with Proteus, such as Alcaligenes, but the very few infections caused by these organisms during our study were unlikely to achieve statistical significance. The lack of association of Enterobacter, Klebsiella, and Citrobacter with Proteus cannot be attributed to low numbers of infections, as these organisms are relatively common. Perhaps these organisms, unlike Proteus, have an equal propensity to infect healthy and diseased urinary tracts. Of the organisms found to be associated with stones, one of these, Enterococcus, does not make urease. We suspect that the strong association of this nosocomial pathogen with Proteus bacteriuria accounts for its association with stones.

Proteus has previously been reported as a common cause of bacteriuria in chronically catheterized residents of long-term care facilities.8 Furthermore, the relationship between Proteus bacteriuria and urinary catheter encrustation and blockage is well documented.9,10 Proteus bacteriuria has likewise been documented in persons with SCI,1,11,12 but not specifically in association with stones. Two retrospective reports published two decades ago of almost 6000 patients with SCI found that bladder calculi were associated with the complete injuries and with Klebsiella bacteriuria.2,3 In these studies, Proteus bacteriuria was nearly significantly associated with development of bladder stones within 2 years of hospital discharge for initial injury (P = 0.06). Renal stones were likewise associated with neurologically complete lesions, and having an indwelling catheter showed a trend toward an association with stones. Thus, our results confirm and expand upon these earlier studies. Our Veterans Affairs Medical Center serves a large and diverse population of SCI patients, so we suspect that our results would also be applicable to other predominantly male SCI populations. As only 2% of our SCI subjects were female, we cannot presume that our results can be generalized to women with SCI.

Our study has several limitations. Like all retrospective studies, we relied on data reported in the medical record. We looked at all urine culture results on SCI subjects during the study period, but we do not know the reason why urine was cultured at a given time. The computerized medical record did not adequately capture data about catheter blockage; hence we were unable to study that outcome. Dates at which catheter management strategies changed were likewise not recorded; therefore, we cannot report a temporal relationship between bladder management strategies and Proteus bacteriuria or stones. We also suspect that the data on substance abuse were unreliable, both because physicians may not always record this information and because patients may not disclose the extent of their substance use. The apparent protective effect of tobacco use on Proteus bladder infection could be attributed to the fact that subjects with lesser degrees of neurological impairment, and thus less likely to have Proteus bacteriuria, had greater opportunities to acquire and smoke cigarettes. As with all observational studies, we can demonstrate associations of various outcomes with Proteus bacteriuria, but we cannot prove causality.

Proteus is extremely diKcult to eradicate from the catheterized urinary tract. In a study that investigated the molecular epidemiology of catheter-associated bladder infections with Proteus, the same strain of Proteus persisted in one patient over 121 days despite eight catheter changes, a 20-day period without catheterization, and an 8-day course of antibiotics.9 In our own study of bladder colonization with benign E. coli in patients with SCI and indwelling urinary catheters, we were unable to eradicate Proteus bacteriuria in four of four subjects despite a week of targeted antibiotics accompanied by catheter change during the course of antibiotics.13 Two of these subjects developed catheter encrustation and blockage within <3 weeks. As we have confirmed that the same SCI patients who are infected with Proteus are likely to experience complications such as stones and catheter encrustation, a more effective approach to clearing this organism from the urinary tract is needed. Urinary catheters inflated with triclosan prevented catheter colonization and biofilm formation by Proteus in vitro.14 Microbicins, or natural antibiotics produced by bacteria, may offer another defensive strategy against Proteus, but as yet we have only used microbicins against E. coli in vitro.15 The data that we have collected on the conditions associated with Proteus bacteriuria in SCI patients indicate that bladder colonization with Proteus is harmful, and we anticipate using this information to design future clinical studies targeting this pathogen.

References

  • 1.Stover S, Lloyd K, Waites K, Jackson A. Urinary tract infection in spinal cord injury. Arch Phys Med Rehabil. 1989;70:47–54. [PubMed] [Google Scholar]
  • 2.DeVivo MJ, Fine PR, Cutter GR, Maetz HM. The risk of renal calculi in spinal cord injury patients. J Urol. 1984;131:857–860. doi: 10.1016/s0022-5347(17)50680-1. [DOI] [PubMed] [Google Scholar]
  • 3.DeVivo MJ, Fine PR, Cutter GR, Maetz HM. The risk of bladder calculi in patients with spinal cord injuries. Arch Intern Med. 1985;145:428–430. doi: 10.1001/archinte.145.3.428. [DOI] [PubMed] [Google Scholar]
  • 4.Rodman JS. Struvite stones. Nephron. 1999;81:9–50. doi: 10.1159/000046299. [DOI] [PubMed] [Google Scholar]
  • 5.Li X, Zhao H, Lockatell CV, Drachenberg CB, Johnson DE, Mobley HL. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun. 2002;70:389–394. doi: 10.1128/IAI.70.1.389-394.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jones BD, Mobley HL. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect Immun. 1987;55:2198–2203. doi: 10.1128/iai.55.9.2198-2203.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mobley HL, Belas R. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol. 1995;3:280–284. doi: 10.1016/s0966-842x(00)88945-3. [DOI] [PubMed] [Google Scholar]
  • 8.Warren J, Tenney J, Hoopes J, Muncle H, Anthony W. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146:719–723. doi: 10.1093/infdis/146.6.719. [DOI] [PubMed] [Google Scholar]
  • 9.Sabbuba N, Mahenthiralingam E, Stickler D. Molecular epidemiology of Proteus mirabilis infections of the catheterized urinary tract. J Clin Micro. 2003;41:4961–4965. doi: 10.1128/JCM.41.11.4961-4965.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Stickler D, Ganderton L, King J, Nettleton J, Winters C. Proteus mirabilis biofilms and the encrustation of urethral catheters. Urol Res. 1993;21:407–411. doi: 10.1007/BF00300077. [DOI] [PubMed] [Google Scholar]
  • 11.Biering-Sorensen F, Bagi P, Hoiby N. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs. 2001;61:1275–1287. doi: 10.2165/00003495-200161090-00004. [DOI] [PubMed] [Google Scholar]
  • 12.Waites KB, Canupp KC, DeVivo MJ. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil. 1993;74:691–695. doi: 10.1016/0003-9993(93)90026-7. [DOI] [PubMed] [Google Scholar]
  • 13.Trautner BW, Hull RA, Thornby JI, Darouiche RO. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol. doi: 10.1086/510872. (in press) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jones GL, Muller CT, O’Reilly M, Stickler DJ. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J Antimicrob Chemother. 2006;57:266–272. doi: 10.1093/jac/dki447. [DOI] [PubMed] [Google Scholar]
  • 15.Trautner BW, Hull RA, Darouiche RO. Colicins prevent colonization of urinary catheters. Journal of Antimicrobial Chemotherapy. 2005;56:413–415. doi: 10.1093/jac/dki228. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES